Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2025-12-24 @ 11:39 PM
NCT ID:
NCT00494351
Eligibility Criteria:
Inclusion Criteria:
For inclusion, the subject must:
* Be at least 18 years old
* Be otherwise healthy
* Have a diagnosis of HS
* Patients with Hurley stage II, with one ore more widely separated recurrent abscesses, with a tract and scarring, bilateral and symmetrical, will be eligible for inclusion in the study.
* Agree to abide by the Investigator's guidelines regarding photosensitizing drugs
* Be able to understand the requirements of the study, the risks involved, and be able to sign the informed consent form
* Agree to follow and undergo all study-related procedures.
Exclusion Criteria:
* Patients with Hidradenitis Hurley state I and III will be excluded from participation in the study.
* The control for this study will be the patient's opposite side of the body, i.e., for patients treated on the left axilla, the right axilla will serve as the corresponding control.
* Concomitant use of systemic or topical treatments for HS. Patients must discontinue all forms of oral therapy as systemic and topical antibiotics and retinoids for 2 weeks prior to the start of any treatment.
* Exacerbation of the patient's original condition expressed clinically by a shift from Hurley Stage II to Stage III.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00494351
Study Brief:
Protocol Section:
NCT00494351